Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease

35Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Psoriasis is a common chronic inflammatory skin disease, associated with significant comorbidity, for example, metabolic syndrome (MetS) and coronary heart disease (CHD). This association implies that the risk to develop these diseases is commonly controlled or that the presence of one disease favours manifestation of the other. Therefore, we assessed the catalogue of genome-wide association studies (GWAS) to analyse whether psoriasis, MetS and CHD share susceptibility loci. Interestingly, genetic control of psoriasis is almost completely independent from both MetS and CHD. In contrast, MetS and CHD share 10 common loci. Like by GWAS analysis, psoriasis susceptibility genes showed close clustering in Ingenuity Pathway Analysis, while genes conferring susceptibility to MetS and CHD were interlinked separately. These findings lead to the hypothesis that the clinically observed co-occurrence of psoriasis with MetS and CHD may be due to a common environmental factor, for example, diet, which is known as a risk factor for all of these diseases. © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Cite

CITATION STYLE

APA

Gupta, Y., Möller, S., Zillikens, D., Boehncke, W. H., Ibrahim, S. M., & Ludwig, R. J. (2013, August). Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease. Experimental Dermatology. https://doi.org/10.1111/exd.12192

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free